VYZULTA ®: A unique molecule for reducing intraocular pressure

Danica Marrelli, OD, FAAO discusses the clinical data on Vyzulta (latanoprostene bunod ophthalmic solution), one of Bausch + Lomb's newest pharmaceutical portfolio additions. Vyzulta is an ophthalmic solution that can help reduce intraocular pressure.
To sign up for our next virtual event, visit events.eyesone... 💻
Subscribe, like, and turn on post notifications! 🔔
Like us on Facebook 👍 / eyesoneyecar. .
Follow us on Instagram 📷 / eyesoneyeca. .